Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 0.220 | 0.390 | 0.170 |
Stocks | 99.770 | 99.770 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 22.257 | 21.466 |
Price to Book | 4.859 | 4.305 |
Price to Sales | 2.397 | 2.555 |
Price to Cash Flow | 16.111 | 14.430 |
Dividend Yield | 0.885 | 1.478 |
5 Years Earnings Growth | 14.515 | 11.617 |
Name | Net % | Category Average |
---|---|---|
Technology | 31.070 | 24.808 |
Consumer Cyclical | 17.440 | 10.775 |
Industrials | 13.380 | 9.660 |
Financial Services | 12.700 | 16.316 |
Communication Services | 9.340 | 8.405 |
Healthcare | 8.700 | 14.546 |
Consumer Defensive | 4.050 | 7.266 |
Real Estate | 1.540 | 2.305 |
Basic Materials | 0.940 | 3.133 |
Energy | 0.840 | 3.772 |
Number of long holdings: 156
Number of short holdings: 45
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Microsoft Corp | - | 6.84 | - | - | |
NVIDIA Corp | - | 4.80 | - | - | |
Apple Inc | - | 3.69 | - | - | |
Amazon.com Inc | - | 3.56 | - | - | |
Meta Platforms Inc Class A | - | 2.89 | - | - | |
Alphabet Inc Class A | - | 2.60 | - | - | |
EMCOR Group Inc | - | 2.05 | - | - | |
Salesforce Inc | - | 1.88 | - | - | |
Medpace Holdings Inc | - | 1.82 | - | - | |
Alphabet Inc Class C | - | 1.80 | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
HSBC Dividend Fund Investor Series | 1.09B | 2.14 | 8.64 | 6.54 | ||
HSBC US Equity Fund Investor Sr | 661.52M | 11.44 | 8.94 | 12.33 | ||
HSBC Small Cap Growth Fund Investor | 252.21M | 5.99 | 0.11 | 5.79 | ||
HSBC Global Equity Fund Investor Sr | 246.6M | 8.14 | 9.24 | 8.21 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review